The future picture isn’t good

0.00 avg. rating (0% score) - 0 votes

Global use of pharmaceuticals is expected to continue growing, especially with the aging population in developed countries and emerging diseases such as SARS-CoV-2. Whereas we can hope that CO2 of big pharma can be reduced with more pressure from shareholders and international communities, the worrying effects of the drugs residue in the environment seem to get altered.